haemophilus B conjugate (meningococcal protein conjugate) and hepatitis B (recombinant) vaccine

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug Namehaemophilus B conjugate (meningococcal protein conjugate) and hepatitis B (recombinant) vaccine
Drug Alias Nameไน™ๅž‹ๆตๆ„Ÿๅ—œ่ก€ๆ†่Œๅ’Œไน™ๅž‹่‚็‚Ž็–ซ่‹—ไน™ๅž‹ๆตๆ„Ÿๅ—œ่ก€ๆ†่Œ๏ผˆa็พค่„‘่†œ็‚Ž็ƒ่Œ็ป“ๅˆ่›‹็™ฝ๏ผ‰ๅ’Œไน™ๅž‹่‚็‚Ž๏ผˆ้‡็ป„๏ผ‰็–ซ่‹—procomvax
ClassificationVaccines > Development/production technology > Conjugated vaccineVaccines > Biological material > Bacterial vaccineVaccines > Application > Prophylactic vaccine +[4]ย 
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsHepatitis B
Global Approved IndicationsHepatitis B
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved Date1999/05/07
Country/TerritoryN/A
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesSanofi Pasteur
China Registration ClassN/A

Develop Information

Active CompaniesSanofi
Inactive CompaniesN/A
Active IndicationsHepatitis B
Inactive IndicationsN/A

Other Information

ATC CodeJ07AG01
Related LinksN/A